Frequently Asked Questions
The Lupus Nephritis Market will grow at a CAGR of 6.80% during the forecast period of 2022 to 2029.
The significant factors flourishing the growth of the Lupus Nephritis Market are Availability of the treatment, and new drugs under pipeline.
The major players operating in the Lupus Nephritis Market are F. Hoffmann-La Roche Ltd, AstraZeneca, Aurinia Pharmaceuticals Inc., GlaxoSmithKline plc., Bristol-Myers Squibb Company, Eli Lilly and Company, Merck & Co., Inc. Novartis AG, Pfizer Inc., Vertice Pharma, Pharmaceutical Associates Inc., Sun Pharmaceutical Industries Ltd, Abbott, Johnson & Johnson Private Limited, Bayer AG, Sanofi, Sumitomo Corporation, LEO Pharma A/S, Cipla Inc., and Nimble Pharmaceuticals among others.
Increasing challenges in research and development and the high cost of treatment are poised to restrict the Lupus Nephritis Market growth.
